Liver Cirrhosis - Disease Information

Overview

Liver cirrhosis is the end result of chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue, and regenerative nodules leading to loss of liver function. It represents the final common pathway for a wide variety of liver diseases and is a major cause of morbidity and mortality worldwide.

Global Impact: Cirrhosis is the 11th leading cause of death globally, accounting for approximately 1.2 million deaths annually. The prevalence is increasing worldwide, with alcoholic liver disease and NAFLD becoming major contributors in developed countries.

Etiology & Causes

Common Causes:

Category	Specific Causes	Prevalence
Viral	Hepatitis B, Hepatitis C	30-40% globally
Alcoholic	Chronic excessive alcohol consumption	20-30% in Western countries
Metabolic	NAFLD, NASH, Wilson's disease, Hemochromatosis	Increasing worldwide
Autoimmune	Autoimmune hepatitis, Primary biliary cholangitis	5-10%
Biliary	Primary sclerosing cholangitis, Biliary atresia	5-10%
Drug-induced	Methotrexate, Amiodarone, Vitamin A toxicity	2-5%
Cryptogenic	Unknown cause (often burnt-out NASH)	5-15%

Pathophysiology

Key Mechanisms:

Hepatocyte injury: Ongoing damage from various causes
Inflammation: Activation of Kupffer cells and inflammatory cascade
Fibrosis: Activation of hepatic stellate cells → collagen deposition
Regeneration: Formation of regenerative nodules
Architectural distortion: Loss of normal liver architecture

Consequences of Cirrhosis:

Portal hypertension: Increased resistance to blood flow
Hepatocellular dysfunction: Impaired synthetic and metabolic functions
Portosystemic shunting: Development of collateral circulation
Hepatic encephalopathy: Impaired ammonia metabolism

Clinical Presentation

Compensated Cirrhosis:

Often asymptomatic or mild symptoms
Fatigue, weakness, weight loss
Mild hepatomegaly
Spider angiomas, palmar erythema
Laboratory abnormalities only

Decompensated Cirrhosis:

Complication	Clinical Features	Prevalence in Decompensated Cirrhosis
Ascites	Abdominal distension, fluid wave, shifting dullness	50-60%
Variceal Bleeding	Hematemesis, melena, hypotension	30-40%
Hepatic Encephalopathy	Confusion, asterixis, coma	30-45%
Jaundice	Yellow skin/sclera, dark urine, pruritus	60-70%
Hepatorenal Syndrome	Oliguria, rising creatinine	10-15%

Diagnosis & Staging

Diagnostic Approach:

Clinical assessment: History, physical examination
Laboratory tests: Liver function tests, coagulation profile
Imaging: Ultrasound, CT, MRI, elastography
Histology: Liver biopsy (gold standard)

Child-Pugh Classification:

Parameter	1 point	2 points	3 points
Bilirubin (mg/dL)	<2	2-3	>3
Albumin (g/dL)	>3.5	2.8-3.5	<2.8
INR	<1.7	1.7-2.3	>2.3
Ascites	None	Mild	Moderate-severe
Encephalopathy	None	Grade 1-2	Grade 3-4
Class	A (5-6 points)	B (7-9 points)	C (10-15 points)

Ayurvedic Treatment

Ayurvedic Perspective:

Liver cirrhosis is considered Yakrit Kshaya or Yakrit Vriddhi with involvement of all three doshas - primarily Pitta and Vata, with Kapha in ascites. It represents Dhatu kshaya (tissue depletion) with Srotorodha (channel blockage).

Herbal Formulations:

Arogyavardhini Vati: Primary formulation for liver disorders
Punarnavadi Mandoor: For anemia, edema, and liver support
Kumaryasava: Aloe-based fermentation for liver regeneration
Rohitakarishta: For liver inflammation and enlargement
Phalatrikadi Kwath: Decoction for deep-seated Pitta disorders
Chandraprabha Vati: For chronic inflammation and fluid balance

Single Herbs:

Herb	Properties	Specific Benefits for Cirrhosis
Bhūnimba (Andrographis paniculata)	Hepatoprotective, anti-fibrotic, anti-inflammatory	Reduces liver fibrosis, protects hepatocytes
Bhṛṅgarāja (Eclipta alba)	Hepatoprotective, rejuvenative, anti-fibrotic	Liver regeneration, reduces portal pressure
Punarnavā (Boerhavia diffusa)	Diuretic, anti-inflammatory, hepatoprotective	Reduces ascites and edema, supports liver function
Gudūchi (Tinospora cordifolia)	Immunomodulator, hepatoprotective, rasayana	Enhances immunity, reduces inflammation
Haridrā (Curcuma longa)	Anti-inflammatory, antioxidant, anti-fibrotic	Reduces inflammation, inhibits stellate cell activation
Yashtimadhu (Glycyrrhiza glabra)	Anti-inflammatory, immunomodulator, demulcent	Reduces liver inflammation, protects mucosa
Kumārī (Aloe vera)	Cooling, rejuvenative, anti-inflammatory	Liver regeneration, reduces Pitta
Shilājit (Asphaltum)	Rejuvenative, adaptogen, mineral-rich	Overall rejuvenation, enhances cellular function

Ayurvedic Procedures:

Virechana (Therapeutic Purgation): For Pitta elimination and detoxification
- Reduces portal hypertension
- Improves liver function
- Enhances drug bioavailability
Basti (Medicated Enema): For Vata pacification and fluid balance
- Niruha Basti: Herbal decoction for cleansing
- Anuvasana Basti: Oil enema for nourishment
Raktamokshana (Bloodletting): For advanced Rakta dhatu vitiation
Udvartana: Herbal powder massage for toxin elimination
Pizhichil: Oil bath therapy for overall rejuvenation

Dietary Recommendations (Ahara):

Essential Nutrients:
- High-quality protein (1.2-1.5 g/kg/day)
- Complex carbohydrates and fiber
- Healthy fats (MCT oil, ghee)
- Adequate vitamins and minerals
Recommended Foods:
- Well-cooked vegetables and fruits
- Whole grains (rice, barley, oats)
- Legumes (moong dal, lentils)
- Lean proteins (chicken, fish, paneer)
- Herbal teas and fresh juices
Foods to Avoid:
- Alcohol and tobacco completely
- Raw and uncooked foods
- Spicy, oily, and fried foods
- Processed and packaged foods
- Excessive salt and sugar

Lifestyle Modifications (Vihara):

Activity Guidelines:
- Moderate walking (15-30 minutes daily)
- Gentle yoga and breathing exercises
- Avoid strenuous activities
- Adequate rest and sleep
Stress Management:
- Regular meditation and relaxation
- Pranayama (Nadi shodhana, Bhramari)
- Avoid emotional stress and anger
- Maintain positive social support
General Precautions:
- Avoid hepatotoxic medications
- Regular medical follow-up
- Vaccination against hepatitis A and B
- Avoid infections and maintain hygiene

Ayurvedic Management Strategy: Comprehensive approach includes Shodhana (purification), Shamana (symptom relief), Bṛṃhaṇa (nourishment), and Rasayana (rejuvenation) therapies tailored to the stage of cirrhosis and individual constitution.

Complications & Management

Major Complications:

Complication	Management	Prevention
Ascites	Salt restriction, diuretics, paracentesis	Early treatment of liver disease
Variceal Bleeding	Band ligation, TIPS, vasoactive drugs	Non-selective beta-blockers
Hepatic Encephalopathy	Lactulose, rifaximin, protein restriction	Avoid precipitating factors
Hepatorenal Syndrome	Vasoconstrictors, albumin, dialysis	Avoid nephrotoxic drugs
HCC Surveillance	Ultrasound every 6 months	Treatment of underlying cause

Prognosis

Variable depending on etiology, stage, and complications. Compensated cirrhosis has 5-year survival of 80-90%, while decompensated cirrhosis has 5-year survival of 20-50%. Liver transplantation offers the best chance for long-term survival in eligible candidates.

Prognostic Scores:

Child-Pugh score: Class A (good), B (moderate), C (poor)
MELD score: Model for End-stage Liver Disease (3-40)
MELD-Na score: Includes sodium for better prediction

When to Seek Emergency Care

Seek immediate medical attention for:

Vomiting blood or coffee-ground material
Black, tarry stools
Severe abdominal pain and distension
Confusion, drowsiness, or coma
High fever with chills
Decreased urine output
Rapid breathing or shortness of breath
Jaundice with worsening symptoms

Prevention & Screening

Primary Prevention:

Vaccination against hepatitis B
Treatment of chronic hepatitis B and C
Alcohol moderation or abstinence
Healthy diet and weight management
Avoid hepatotoxic medications

Secondary Prevention:

Regular monitoring of liver function
Screening for varices in cirrhosis
HCC surveillance every 6 months
Vaccination against hepatitis A and influenza
Nutritional support and supplementation